Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 1999 December;11(4) > Minerva Biotecnologica 1999 December;11(4):325-334

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,25


eTOC

 

  TUMOR IMMUNOLOGYFREEfree


Minerva Biotecnologica 1999 December;11(4):325-334

Copyright © 1999 EDIZIONI MINERVA MEDICA

language: English

Immune recognition and immunotherapy in hematological malignancies

Orsini E., Guarini A., Torelli G., Foà R.

Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi di Roma “La Sapienza”, Roma; Dipartimento di Scienze Biomediche e Oncologia Umana, Università degli Studi di Torino, Torino, Italy


FULL TEXT  


In the present review, we shall discuss how immunotherapy has, over the last 15 years, become a prominent part of the therapeutic armamentarium for different types of hematological malignancies. We will also focus on new prospects in rapid and promising development, as well as on possibilities of inducing immune-mediated recognition of leukemia and lymphoma cells.

top of page

Publication History

Cite this article as

Corresponding author e-mail